FDA approves 1st nonreplicating smallpox, monkeypox vaccine

The FDA has approved Jynneos, a smallpox and monkeypox live and nonreplicating vaccine. 

Advertisement

It is the only vaccine approved by the FDA for monkeypox and the first live, non-replicating vaccine to prevent both diseases. 

Jynneos, approved for adults, will be available to those determined to be at high risk of acquiring smallpox or monkeypox.

More articles on pharmacy:
World Pharmacist Day promotes use of safe and effective medicines
USP delays release of updated compounding standards
Americans pay up to 67 times more for drugs than other countries

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.